Results 161 to 170 of about 32,341 (221)

Clinical and molecular features of neurofibromatosis types 1 and 2: a review of the literature

, 2022
D. Polatova, А. V. Savkin, Н.К. Асамединов, R. Davletov, A. I. Nurzhabov, S. K. Nasirov   +5 more
openalex   +2 more sources

Efficacy of Combined Dabrafenib and Trametinib Therapy in BRAFV600E Mutant Intrahepatic Cholangiocarcinoma with a Neurofibromatosis Type 2 Mutation. [PDF]

Intern Med
Yoshida J, Sugiyama K, Owaki S, Ito T, Yamaguchi Y, Emi R, Sako Y, Satoh M, Ino R, Kato K, Shiraishi K, Shimada M, Hattori H, Kitagawa C.   +13 more
europepmc   +1 more source

Origins of biallelic inactivation of NF2 in neurofibromatosis type 2. [PDF]

Neuro Oncol, 2022
Xue L, He W, Zhang Y, Wang Z, Chen H, Chen Z, Zhu W, Liu D, Jia H, Jiang Y, Wang Z, Wu H, Wu H.   +12 more
europepmc   +1 more source

Bevacizumab for Vestibular Schwannomas in Neurofibromatosis Type 2: A Systematic Review of Tumor Control and Hearing Preservation. [PDF]

J Clin Med
Screnci M, Puechmaille M, Berton Q, Khalil T, Mom T, Coll G.   +5 more
europepmc   +1 more source

Phenotypic and molecular characterization of a novel mouse model of neurofibromatosis type 2

, 2015
Jeff Gehlhausen
openalex   +1 more source

Erratum: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2. [PDF]

Mol Ther Methods Clin Dev
Prabhakar S, Beauchamp RL, Cheah PS, Yoshinaga A, Abou Haidar E, Lule S, Mani G, Maalouf K, Stemmer-Rachamimov A, Jung DH, Welling DB, Giovannini M, Plotkin SR, Maguire CA, Ramesh V, Breakefield XO.   +15 more
europepmc   +1 more source

Neurofibromatosis Type 2 Presenting as Symptomatic Gallbladder Hydrops: A Rare Case Report and Literature Review. [PDF]

Case Rep Pediatr
Hafez B, Alwan JS, El Hout W, Koussa K, El Annan T, Noun D, Zaghal A.   +6 more
europepmc   +1 more source

Retinal Ischemia as a Presenting Ocular Sign of Neurofibromatosis Type 2. [PDF]

Case Rep Ophthalmol Med
Zhao B, Yan Y.
europepmc   +1 more source

Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions. [PDF]

Oncol Ther
Yuan R, Wang B, Wang Y, Liu P.
europepmc   +1 more source

VEGF Receptors Peptide Vaccine in Neurofibromatosis Type 2: A Single-Arm, Open-Label, Phase 1/2 Trial

, 2019
Ryota Tamura, Masato Fujioka, Yukina Morimoto, Kentaro Ohara, Kenzo Kosugi, Yumiko Oishi, Mizuto Sato, Ryo Ueda, Hirokazu Fujiwara, Shinobu Noji, Naoki Oishi, Kaoru Ogawa, Yutaka Kawakami, Takayuki Ohira, Kazunari Yoshida, Masahiro Toda   +15 more
openalex   +1 more source